| Home | E-Submission | Sitemap | Contact Us |  
top_img
Cancer Research and Treatment > Volume 33(3); 2001 > Article
Cancer Research and Treatment 2001;33(3): 269-273. doi: https://doi.org/10.4143/crt.2001.33.3.269
A Case of Primary MALT Lymphoma of the Breast
Si Wook Jung, Byung Seok Kim, Jae Hong Park, Seong Kyu Kim, Hyang Eun Seo, Dong Kun Shin, Jung Lim Lee, Ik Su Kim, Dong Seok Lee, Dong Seok Kim
1Department of Internal Medicine, Fatima Hospital.
2Department of Pathology, Fatima Hospital.
3Seoul Breast Clinic.
4Department of Pathology, Yeungnam University School ofMedicine, Daegu, Korea.
  Published online: June 30, 2001.
ABSTRACT
Primary malignant lymphoma of the breast is rare. The incidence of primary malignant lymphomas of the breast is 0.04% to 0.5% of all malignant tumors of the breast and 0.07% of all non-Hodgkin's lymphomas, and comprises 1.7% of extranodal malignant lymphomas that occur in Western countries. The incidence of mucosa- associated lymphoid tissue (MALT) lymphoma of the breast is reported to be between 0% and 75% of all primary malignant breast lymphomas in United States and Japan, but the incidence in Korea is unknown. MALT is characterized by indolent behavior and good has a prognosis. The authors report on a patient who has a primary MALT lymphoma of the breast. She was treated by surgical excision, which was followed by radiation therapy. Histologically, her lymphoma type transformed into a diffuse large B-cell tumor after 10months. She received combination chemotherapy and achieved a complete state of remission. She then underwent autologous peripheral blood stem cell transplantation along with high dose chemotherapy. To our knowledge, this is the first case report in the literature in Korea.
Key words: Breast;MALT lymphoma
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association.                 Developed in M2PI